Effects of Laquinimod on Standard Oral Contraceptives

Study Title
A Phase I Study in Young Healthy Women to Investigate the Effects of Laquinimod on Standard Oral Contraceptive When Both Treatments Are Given Together
Teva Identifier
TV5600-PK-10017 | 2013-005356-14
ClinicalTrials.gov Identifier
NCT02085863
Study Status
Completed
Trial Condition(s)
Pharmacokinetics | Pharmacodynamics
Interventions
Drug: laquinimod | Drug: Placebo

Study Description

Please refer to ClinicalTrials.gov for a description of the trial
Print

Participation criteria and map of study locations


Key Participation Requirements

Gender
Female
Age group
Adult
Age Range
18 Years to 40 Years
Trial Duration
02/01/2014 - 11/01/2014
Phase
Phase 1

Study Type

Interventional